West Pharmaceutical Services (WST) Leases (2011 - 2026)

West Pharmaceutical Services' Leases history runs 14 years deep, the most recent figure standing at $110.2 million for Q1 2026.

• In Q1 2026, Leases rose 6.58% year-over-year to $110.2 million; the TTM figure through Mar 2026 stood at $110.2 million (up 6.58% YoY), while the FY2025 annual figure was $117.0 million, up 11.96% from the prior year.
• Leases came in at $110.2 million for Q1 2026 at West Pharmaceutical Services, down from $117.0 million in the prior quarter.
• In the past five years, Leases ranged from a high of $117.0 million in Q4 2025 to a low of $75.6 million in Q1 2022.
• A 5-year average of $99.5 million and a median of $101.1 million in 2023 frame the typical range for Leases.
• Across the five-year window, Leases jumped 50.65% in 2022 and retreated 9.44% in 2025, its largest moves.
• West Pharmaceutical Services' Leases stood at $104.4 million in 2022, then retreated by 4.98% to $99.2 million in 2023, then advanced by 5.34% to $104.5 million in 2024, then climbed by 11.96% to $117.0 million in 2025, then slipped by 5.81% to $110.2 million in 2026.
• According to Business Quant data, Leases over the past three periods registered $110.2 million, $117.0 million, and $97.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison